Skip to content
Clinical Trials – home

Centre Hospitalier Bethune Beuvry

Verifiedinfo

France 27 Rue Delbecque, 62660 Beuvry, France

  • 13 trials recruiting
  • Colon cancer · Gastrooesophageal cancer · Squamous cell carcinoma of head and neck
  • Adult patients

About Specializations

Centre Hospitalier Bethune Beuvry in Beuvry, France specialises in clinical trials of conditions such as Colon cancer, Gastrooesophageal cancer, Squamous cell carcinoma of head and neck, Oesophageal adenocarcinoma, and other specialisations. This site conducts important research.

Main research areas of the site

Infectious Diseases and Critical Care

At Centre Hospitalier Bethune Beuvry, research in bacterial infections and virus diseases focuses on serious hospital-treated conditions such as sepsis, septic shock, and severe resistant infections. These studies aim to improve survival, protect organ function, and identify better treatment options for patients in intensive care.

  • Severe infection management in ICU patients
  • Sepsis and septic shock support therapies
  • Strategies for resistant bacterial infections

Work in this area also includes evaluating whether alternative antimicrobial approaches can match standard care while reducing unnecessary broad-spectrum antibiotic use.

Oncology and Digestive System Cancers

Clinical trials in neoplasms and digestive system diseases explore cancers of the colon, rectum, pancreas, stomach, esophagus, and ampulla. The main goal is to test new treatment combinations and improve long-term control of advanced or resected disease.

  • Colorectal cancer and biomarker-guided treatment
  • Pancreatic and ampullary adenocarcinoma
  • Gastric and esophageal cancers

Several studies are designed to strengthen disease-free survival and progression-free survival by refining how chemotherapy, targeted therapy, and immunotherapy are used.

Head and Neck Cancer Research

Another major area at the site is head and neck oncology, including squamous cell carcinoma of the oral cavity, pharynx, larynx, and related sites. These trials are examining new treatment combinations to improve disease control in locally advanced and recurrent settings.

  • Locally advanced head and neck squamous cell carcinoma
  • Radiotherapy combined with systemic treatments
  • Post-surgical recurrence prevention

The research aims to make treatment more effective while preserving tolerability for patients facing complex cancers of the upper aerodigestive tract.

Neurology and Cognitive Disorders

Trials in nervous system diseases include research on Alzheimer's disease, with a focus on slowing cognitive decline and supporting day-to-day function. This work reflects an effort to find practical therapies that may help patients in the early to moderate stages of dementia.

  • Alzheimer's disease and memory decline
  • Symptom-focused treatment evaluation
  • Support for cognitive preservation

These studies are centered on whether a simple therapeutic approach can offer measurable benefit for cognition and quality of life.

Physiological and Kidney-Related Research

Some studies address reproductive and urinary physiological phenomena and kidney-related complications, including patients with end-stage renal disease on dialysis and those who develop kidney injury during critical illness. The purpose is to better understand safety and treatment choices in medically fragile populations.

  • Kidney complications during septic shock
  • Anticoagulation in peritoneal dialysis patients
  • Safety-focused care in complex chronic illness

At the site, this line of research supports more individualized care for patients with overlapping renal, infectious, and cardiovascular risks.

Bone and Joint Infection Research

Research also includes staphylococcal prosthetic joint infection, a difficult-to-treat form of bacterial infection affecting patients with implanted joints. The aim is to evaluate whether alternative oral treatments can maintain infection control during surgical and medical management.

  • Prosthetic joint infection due to staphylococci
  • Oral treatment options for infection control
  • Improving practical care after joint surgery

This area highlights the site's interest in finding safer and more effective approaches for complex orthopedic infections.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
27 Rue Delbecque62660 BeuvryFrance
Recruiting now
13 trials
Conditions studied
28
Partner status
Verified

More sites in BeuvryFrance

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

24 clinical trials

Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:FRUQUINTINIB
  • Sponsor:Fondation Franc.Cancerologie Digestive
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Tislelizumab
  • Sponsor:University Hospital Of Clermont-Ferrand
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Rifabutin
  • Sponsor:Centre Hospitalier De Tourcoing
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Calcium Folinate
  • Sponsor:Assistance Publique Hopitaux De Paris
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Cetuximab
  • Sponsor:Fondation Franc.Cancerologie Digestive
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Fluorouracil
  • Sponsor:Centre Hospitalier Universitaire De Dijon
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Calcium Folinate
  • Sponsor:Centre Hospitalier Universitaire De Dijon
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Meropenem Anhydrous
  • Sponsor:Assistance Publique Hopitaux De Paris
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Caffeine
  • Sponsor:Centre Hospitalier Universitaire De Lille
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Apixaban
  • Sponsor:Centre Hospitalier Universitaire De Caen Normandie
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Unicancer
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Centre Hospitalier Universitaire De Dijon
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.